Data / Drug companies / Valsartan and hydrochlorothiazide
Valsartan and hydrochlorothiazide: 21 companies and 104 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Valsartan and hydrochlorothiazide is listed in the FDA National Drug Code Directory by 21 companies, with 104 products in commercial distribution. 99 of the products (95.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, and the newest product started marketing on July 27, 2026.
The request: Get every company that lists valsartan and hydrochlorothiazide in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 21
- Products
- 104
- Generic (ANDA) products
- 99 (95.2%)
- Application numbers
- 10
- Routes
- Oral
- Brand names
- Diovan HCT
- openFDA record search
- api.fda.gov
Companies that list valsartan and hydrochlorothiazide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 11 | tablet, film coated; tablet | Generic drugs (ANDA) | May 20, 2016 |
| Bryant Ranch Prepack | 7 | tablet, film coated | Generic drugs (ANDA) | May 20, 2016 |
| Alembic Pharmaceuticals Inc. | 5 | tablet, film coated | Generic drugs (ANDA) | May 20, 2016 |
| Alembic Pharmaceuticals Limited | 5 | tablet, film coated | Generic drugs (ANDA) | May 20, 2016 |
| Amneal Pharmaceuticals LLC | 5 | tablet, film coated | Generic drugs (ANDA) | August 14, 2023 |
| Amneal Pharmaceuticals of New York LLC | 5 | tablet, film coated | Generic drugs (ANDA) | August 14, 2023 |
| Aurobindo Pharma Limited | 5 | tablet, film coated | Generic drugs (ANDA) | March 21, 2013 |
| AvKARE | 5 | tablet, film coated | Generic drugs (ANDA) | September 19, 2023 |
| Golden State Medical Supply, Inc. | 5 | tablet, film coated | Generic drugs (ANDA) | April 23, 2026 |
| Lupin Pharmaceuticals, Inc. | 5 | tablet, film coated | Generic drugs (ANDA) | March 21, 2013 |
| Macleods Pharmaceuticals Limited | 5 | tablet, film coated; tablet | Generic drugs (ANDA) | April 19, 2013 |
| Mylan Pharmaceuticals Inc. | 5 | tablet, film coated | Generic drugs (ANDA) | September 21, 2012 |
| Novartis Pharmaceuticals Corporation | 5 | tablet, film coated | New drug applications (NDA) | April 28, 2006 |
| Proficient Rx LP | 5 | tablet, film coated | Generic drugs (ANDA) | May 20, 2016 |
| Proficient Rx LP | 5 | tablet, film coated | Generic drugs (ANDA) | May 20, 2016 |
| ScieGen Pharmaceuticals, Inc. | 5 | tablet, film coated | Generic drugs (ANDA) | July 27, 2026 |
| Solco Healthcare US, LLC | 5 | tablet, film coated | Generic drugs (ANDA) | October 31, 2015 |
| Zydus Lifesciences Limited | 5 | tablet, film coated | Generic drugs (ANDA) | February 12, 2020 |
| Northwind Health Company, LLC | 4 | tablet, film coated | Generic drugs (ANDA) | March 29, 2023 |
| Bryant Ranch Prepack | 1 | tablet, film coated | Generic drugs (ANDA) | April 19, 2013 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | May 21, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 101 | 97.1% |
| Tablet | 3 | 2.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 99 | 95.2% |
| New drug applications (NDA) | 5 | 4.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Angiotensin 2 Receptor Blocker | 104 |
| Thiazide Diuretic | 104 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.